Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

UBS
McKesson
Harvard Business School
Citi
Accenture
Julphar

Generated: July 18, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089572

Try a free trialSee Plans and Pricing

« Back to Dashboard

NDA 089572 describes PYRIDOSTIGMINE BROMIDE, which is a drug marketed by Novitium Pharma, Alvogen Malta, Impax Labs Inc, Rising, Ani Pharms Inc, Apnar Pharma Lp, Impax Labs, Solvay, Us Army, and Zydus Pharms, and is included in eleven NDAs. It is available from eleven suppliers. Additional details are available on the PYRIDOSTIGMINE BROMIDE profile page.

The generic ingredient in PYRIDOSTIGMINE BROMIDE is pyridostigmine bromide. There are eleven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the pyridostigmine bromide profile page.
Summary for 089572
Tradename:PYRIDOSTIGMINE BROMIDE
Applicant:Solvay
Ingredient:pyridostigmine bromide
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 089572

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength30MG
Approval Date:Nov 27, 1990TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Accenture
Express Scripts
QuintilesIMS
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.